Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Bullinger

Showing results (101-110 of 385) with videos related to

Pageof 39
Sort By:
Leukemia & Lymphoma|February 22, 2021
Cerebral EBV-positive PTLD controlled by PD-1 checkpoint blockade in a liver transplant patientAitomi Bittner, Josefine Radke, Dennis Eurich, et al.
Clinical Epigenetics|October 27, 2023
Predictive value of DNA methylation patterns in AML patients treated with an azacytidine containing induction regimenMaximilian Schmutz, Manuela Zucknick, Richard F Schlenk, et al.
Leukemia|November 16, 2021
Modeling clonal hematopoiesis in umbilical cord blood cells by CRISPR/Cas9Friederike Christen, Raphael Hablesreiter, Kaja Hoyer, et al.
Haematologica|October 29, 2017
Chromothripsis is linked to <i>TP53</i> alteration, cell cycle impairment, and dismal outcome in acute myeloid leukemia with complex karyotypeFrank G Rücker, Anna Dolnik, Tamara J Blätte, et al.
Blood|August 26, 2006
Expression of tumor-associated antigens in acute myeloid leukemia: Implications for specific immunotherapeutic approachesJochen Greiner, Michael Schmitt, Li Li, et al.
Experimental Hematology|September 14, 2016
MicroRNA-155 is upregulated in MLL-rearranged AML but its absence does not affect leukemia developmentEdith Schneider, Anna Staffas, Linda Röhner, et al.
Blood|May 24, 2014
SIRT1 prevents genotoxic stress-induced p53 activation in acute myeloid leukemiaDaniel Sasca, Patricia S Hähnel, Jakub Szybinski, et al.
Blood|August 21, 2008
MYC stimulates EZH2 expression by repression of its negative regulator miR-26aSandrine Sander, Lars Bullinger, Kay Klapproth, et al.
Blood|October 19, 2018
Nuclear FOXO1 promotes lymphomagenesis in germinal center B cellsEleni Kabrani, Van Trung Chu, Evangelia Tasouri, et al.
Blood|February 18, 2009
Prognostic impact of WT1 mutations in cytogenetically normal acute myeloid leukemia: a study of the German-Austrian AML Study GroupVerena Ingeborg Gaidzik, Richard Friedrich Schlenk, Simone Moschny, et al.
Pageof 39

Showing results (101-110 of 385) with videos related to

Sort By:
Pageof 39
Leukemia & Lymphoma|February 22, 2021
Cerebral EBV-positive PTLD controlled by PD-1 checkpoint blockade in a liver transplant patientAitomi Bittner, Josefine Radke, Dennis Eurich, et al.
Clinical Epigenetics|October 27, 2023
Predictive value of DNA methylation patterns in AML patients treated with an azacytidine containing induction regimenMaximilian Schmutz, Manuela Zucknick, Richard F Schlenk, et al.
Leukemia|November 16, 2021
Modeling clonal hematopoiesis in umbilical cord blood cells by CRISPR/Cas9Friederike Christen, Raphael Hablesreiter, Kaja Hoyer, et al.
Haematologica|October 29, 2017
Chromothripsis is linked to <i>TP53</i> alteration, cell cycle impairment, and dismal outcome in acute myeloid leukemia with complex karyotypeFrank G Rücker, Anna Dolnik, Tamara J Blätte, et al.
Blood|August 26, 2006
Expression of tumor-associated antigens in acute myeloid leukemia: Implications for specific immunotherapeutic approachesJochen Greiner, Michael Schmitt, Li Li, et al.
Experimental Hematology|September 14, 2016
MicroRNA-155 is upregulated in MLL-rearranged AML but its absence does not affect leukemia developmentEdith Schneider, Anna Staffas, Linda Röhner, et al.
Blood|May 24, 2014
SIRT1 prevents genotoxic stress-induced p53 activation in acute myeloid leukemiaDaniel Sasca, Patricia S Hähnel, Jakub Szybinski, et al.
Blood|August 21, 2008
MYC stimulates EZH2 expression by repression of its negative regulator miR-26aSandrine Sander, Lars Bullinger, Kay Klapproth, et al.
Blood|October 19, 2018
Nuclear FOXO1 promotes lymphomagenesis in germinal center B cellsEleni Kabrani, Van Trung Chu, Evangelia Tasouri, et al.
Blood|February 18, 2009
Prognostic impact of WT1 mutations in cytogenetically normal acute myeloid leukemia: a study of the German-Austrian AML Study GroupVerena Ingeborg Gaidzik, Richard Friedrich Schlenk, Simone Moschny, et al.
Pageof 39